메뉴 건너뛰기




Volumn 56, Issue 1, 2014, Pages 77-82

Incidence and index of severity of hemolytic uremic syndrome in a 26 year period in Fukushima Prefecture, Japan

Author keywords

epidemiology; hemolytic uremic syndrome; incidence; renal insufficiency; severity

Indexed keywords

ALANINE AMINOTRANSFERASE; CREATININE; FIBRINOGEN DEGRADATION PRODUCT; FUROSEMIDE; GABEXATE MESILATE; LACTATE DEHYDROGENASE; NAFAMSTAT MESILATE; SERUM ALBUMIN;

EID: 84894484142     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/ped.12193     Document Type: Article
Times cited : (7)

References (24)
  • 1
    • 0021946215 scopus 로고
    • The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli
    • Karmali MA, Petric M, Lim C, Fleming DC, Arthus GS, Lior H,. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J. Infect. Dis. 1985; 151: 775-782.
    • (1985) J. Infect. Dis. , vol.151 , pp. 775-782
    • Karmali, M.A.1    Petric, M.2    Lim, C.3    Fleming, D.C.4    Arthus, G.S.5    Lior, H.6
  • 2
    • 79954441390 scopus 로고    scopus 로고
    • Advances in our understanding of the pathogenesis of glomerular thrombotic microangiopathy
    • Keir L, Coward RJ,. Advances in our understanding of the pathogenesis of glomerular thrombotic microangiopathy. Pediatr. Nephrol. 2011; 26: 523-533.
    • (2011) Pediatr. Nephrol. , vol.26 , pp. 523-533
    • Keir, L.1    Coward, R.J.2
  • 3
    • 77957588040 scopus 로고    scopus 로고
    • Pathophysiology of typical hemolytic uremic syndrome
    • Karpman D, Sartz L, Johnson S,. Pathophysiology of typical hemolytic uremic syndrome. Semin. Thromb. Hemost. 2010; 36: 575-585.
    • (2010) Semin. Thromb. Hemost. , vol.36 , pp. 575-585
    • Karpman, D.1    Sartz, L.2    Johnson, S.3
  • 4
    • 51549116628 scopus 로고    scopus 로고
    • Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS)
    • Scheiring J, Andreoli SP, Zimmerhackl LB,. Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS). Pediatr. Nephrol. 2008; 23: 1749-1760.
    • (2008) Pediatr. Nephrol. , vol.23 , pp. 1749-1760
    • Scheiring, J.1    Andreoli, S.P.2    Zimmerhackl, L.B.3
  • 5
    • 84869239340 scopus 로고    scopus 로고
    • Role of vascular endothelial growth factor and angiopoietin 1 in renal injury in hemolytic uremic syndrome
    • Ohara S, Kawasaki Y, Abe Y, et al. Role of vascular endothelial growth factor and angiopoietin 1 in renal injury in hemolytic uremic syndrome. Am. J. Nephrol. 2013; 36: 516-523.
    • (2013) Am. J. Nephrol. , vol.36 , pp. 516-523
    • Ohara, S.1    Kawasaki, Y.2    Abe, Y.3
  • 6
    • 50249083363 scopus 로고    scopus 로고
    • Risk factors for developing severe clinical course in HUS patients: A national survey in Japan
    • Members of the Japanese Society for Pediatric Nephrology.
    • Kamioka I, Yoshiya K, Satomura K, et al. Members of the Japanese Society for Pediatric Nephrology. Risk factors for developing severe clinical course in HUS patients: A national survey in Japan. Pediatr. Int. 2008; 50: 441-446.
    • (2008) Pediatr. Int. , vol.50 , pp. 441-446
    • Kamioka, I.1    Yoshiya, K.2    Satomura, K.3
  • 7
    • 63549147220 scopus 로고    scopus 로고
    • Risk factors for neurological complications in complete hemolytic uremic syndrome caused by Escherichia coli 157
    • Yamamoto T, Satomura K, Okada S, Ozono K,. Risk factors for neurological complications in complete hemolytic uremic syndrome caused by Escherichia coli 157. Pediatr. Int. 2009; 51: 216-219.
    • (2009) Pediatr. Int. , vol.51 , pp. 216-219
    • Yamamoto, T.1    Satomura, K.2    Okada, S.3    Ozono, K.4
  • 8
    • 34147140549 scopus 로고    scopus 로고
    • Prognosis and pathological characteristic of five children with non-Shiga toxin-mediated hemolytic uremic syndrome
    • Kamioka I, Nozu K, Fujita T, et al. Prognosis and pathological characteristic of five children with non-Shiga toxin-mediated hemolytic uremic syndrome. Pediatr. Int. 2007; 48: 196-201.
    • (2007) Pediatr. Int. , vol.48 , pp. 196-201
    • Kamioka, I.1    Nozu, K.2    Fujita, T.3
  • 9
    • 20144386770 scopus 로고    scopus 로고
    • Childhood hemolytic uremic syndrome, United Kingdom and Ireland
    • Lynn RM, O'Brien SJ, Taylor CM, et al. Childhood hemolytic uremic syndrome, United Kingdom and Ireland. Emerg. Infect. Dis. 2005; 11: 590-596.
    • (2005) Emerg. Infect. Dis. , vol.11 , pp. 590-596
    • Lynn, R.M.1    O'Brien, S.J.2    Taylor, C.M.3
  • 10
    • 0037103517 scopus 로고    scopus 로고
    • Clinical course and the role of Shiga toxin-producing Escherichia coli infection in the haemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: A prospective study
    • Gerber A, Karch H, Allerberger F, Verweyen HM, Zimmerhackl LB,. Clinical course and the role of Shiga toxin-producing Escherichia coli infection in the haemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: A prospective study. J. Infect. Dis. 2002; 186: 493-500.
    • (2002) J. Infect. Dis. , vol.186 , pp. 493-500
    • Gerber, A.1    Karch, H.2    Allerberger, F.3    Verweyen, H.M.4    Zimmerhackl, L.B.5
  • 11
    • 50949103794 scopus 로고    scopus 로고
    • Surveillance of hemolytic uremic syndrome in children less than 15 years of age, a system to monitor O157 and non-O157 Shiga toxin producing Escherichia coli infections in France, 1996-2006
    • Espie E, Grimont F, Mariani-Kurkdjian P, et al. Surveillance of hemolytic uremic syndrome in children less than 15 years of age, a system to monitor O157 and non-O157 Shiga toxin producing Escherichia coli infections in France, 1996-2006. Pediatr. Infect. Dis. J. 2008; 27: 595-601.
    • (2008) Pediatr. Infect. Dis. J. , vol.27 , pp. 595-601
    • Espie, E.1    Grimont, F.2    Mariani-Kurkdjian, P.3
  • 12
    • 0024400037 scopus 로고
    • Hemolytic uremic syndrome and diarrhea in Argentine children: The role of Shiga-like toxins
    • Lopez EL, Diaz M, Grinstein S, et al. Hemolytic uremic syndrome and diarrhea in Argentine children: The role of Shiga-like toxins. J. Infect. Dis. 1989; 160: 469-475.
    • (1989) J. Infect. Dis. , vol.160 , pp. 469-475
    • Lopez, E.L.1    Diaz, M.2    Grinstein, S.3
  • 13
    • 77952096304 scopus 로고    scopus 로고
    • Hemolytic uremic syndrome in Switzerland: A nationwide surveillance 1997-2003
    • Swiss Pediatric Surveillance Unit.
    • Schiffelri A, von Vigier RO, Fontana M, et al. Swiss Pediatric Surveillance Unit. Hemolytic uremic syndrome in Switzerland: A nationwide surveillance 1997-2003. Eur. J. Pediatr. 2010; 169: 591-598.
    • (2010) Eur. J. Pediatr. , vol.169 , pp. 591-598
    • Schiffelri, A.1    Von Vigier, R.O.2    Fontana, M.3
  • 14
    • 0033064066 scopus 로고    scopus 로고
    • Clinical features and treatment of children with hemolytic uremic syndrome caused by enterohemorrhagic Escherichia coli 157:H7 infection: Experience of an outbreak in Sakai City, 1996
    • Yoshioka K, Yagi K, Moriguchi N,. Clinical features and treatment of children with hemolytic uremic syndrome caused by enterohemorrhagic Escherichia coli 157:H7 infection: Experience of an outbreak in Sakai City, 1996. Pediatr. Int. 1999; 41: 223-227.
    • (1999) Pediatr. Int. , vol.41 , pp. 223-227
    • Yoshioka, K.1    Yagi, K.2    Moriguchi, N.3
  • 15
    • 0032997531 scopus 로고    scopus 로고
    • Clinical experiences in Sakai City Hospital during the massive outbreak of enterohemorrhagic Escherichia coli 157 infections in Sakai City, 1996
    • Fukushima H, Hashizume T, Morita Y, et al. Clinical experiences in Sakai City Hospital during the massive outbreak of enterohemorrhagic Escherichia coli 157 infections in Sakai City, 1996. Pediatr. Int. 1999; 41: 213-217.
    • (1999) Pediatr. Int. , vol.41 , pp. 213-217
    • Fukushima, H.1    Hashizume, T.2    Morita, Y.3
  • 16
    • 84865123227 scopus 로고    scopus 로고
    • Encephalopathy, disseminated intravascular coagulation, and hemolytic-uremic syndrome after infection with enterohemorrhagic Escherichia coli O111
    • Matano S, Inamura K, Konishi M, et al. Encephalopathy, disseminated intravascular coagulation, and hemolytic-uremic syndrome after infection with enterohemorrhagic Escherichia coli O111. J. Infect. Chemother. 2012; 18: 558-564.
    • (2012) J. Infect. Chemother. , vol.18 , pp. 558-564
    • Matano, S.1    Inamura, K.2    Konishi, M.3
  • 17
    • 84906939751 scopus 로고    scopus 로고
    • Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease
    • doi: 10.1007/s10157-013-0856-y
    • Uemura O, Nagai T, Ishikura K, et al. Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease. Clin. Exp. Nephrol. 2013. doi: 10.1007/s10157-013- 0856-y
    • (2013) Clin. Exp. Nephrol.
    • Uemura, O.1    Nagai, T.2    Ishikura, K.3
  • 18
    • 70350279315 scopus 로고    scopus 로고
    • Atypical hemolytic-uremic syndrome
    • Noris M, Remuzzi G,. Atypical hemolytic-uremic syndrome. N. Engl. J. Med. 2009; 22: 1676-1687.
    • (2009) N. Engl. J. Med. , vol.22 , pp. 1676-1687
    • Noris, M.1    Remuzzi, G.2
  • 19
    • 0024148809 scopus 로고
    • Prognostic factors in typical postdiarrhea hemolytic-uremic syndrome
    • Robson WL, Fick GH, Wilson PC,. Prognostic factors in typical postdiarrhea hemolytic-uremic syndrome. Child Nephrol. Urol. 1988; 89: 203-207.
    • (1988) Child Nephrol. Urol. , vol.89 , pp. 203-207
    • Robson, W.L.1    Fick, G.H.2    Wilson, P.C.3
  • 20
    • 0033783260 scopus 로고    scopus 로고
    • Usefulness of serum fibrinogen product-E in sporadic cases of classical hemolytic uremic syndrome
    • Aihara Y, Nakamura T, Unayama T, Yoshida Y, Yokota S,. Usefulness of serum fibrinogen product-E in sporadic cases of classical hemolytic uremic syndrome. Pediatr. Int. 2000; 42: 523-527.
    • (2000) Pediatr. Int. , vol.42 , pp. 523-527
    • Aihara, Y.1    Nakamura, T.2    Unayama, T.3    Yoshida, Y.4    Yokota, S.5
  • 21
    • 0018903835 scopus 로고
    • CNS manifestations of the hemolytic-uremic syndrome. Relationship to metabolic alterations and prognosis
    • Bale JF Jr, Brasher C, Siegler RL,. CNS manifestations of the hemolytic-uremic syndrome. Relationship to metabolic alterations and prognosis. Am. J. Dis. Child. 1980; 134: 869-872.
    • (1980) Am. J. Dis. Child. , vol.134 , pp. 869-872
    • Bale, Jr.J.F.1    Brasher, C.2    Siegler, R.L.3
  • 22
    • 0024595998 scopus 로고
    • Hyponatraemia and haemolytic uremic syndrome
    • Milford D, Taylor CM,. Hyponatraemia and haemolytic uremic syndrome. Lancet 1989; 25 1(8635): 439.
    • (1989) Lancet , vol.25 , Issue.8635 , pp. 439
    • Milford, D.1    Taylor, C.M.2
  • 24
    • 34248359998 scopus 로고    scopus 로고
    • Continuous renal replacement therapy in neonates and young infants during extracorporeal membrane oxygenation
    • Cavagnaro F, Kattan J, Godoy L, et al. Continuous renal replacement therapy in neonates and young infants during extracorporeal membrane oxygenation. Int. J. Artif. Organs 2007; 30: 220-226.
    • (2007) Int. J. Artif. Organs , vol.30 , pp. 220-226
    • Cavagnaro, F.1    Kattan, J.2    Godoy, L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.